Hypothalamic dysfunction and neuroendocrine and metabolic alterations in Huntington's disease: clinical consequences and therapeutic implications
- PMID: 18019608
- DOI: 10.1515/revneuro.2007.18.3-4.223
Hypothalamic dysfunction and neuroendocrine and metabolic alterations in Huntington's disease: clinical consequences and therapeutic implications
Abstract
Huntington's disease (HD) is a hereditary neurodegenerative disorder characterized by cognitive, psychiatric, behavioural and motor disturbances. Although the course of HD is also frequently complicated by unintended weight loss, sleep disturbances and autonomic nervous system dysfunction, the aetiology of these signs and symptoms remains largely unknown. In recent years, many novel findings from both animal and human studies have emerged that indicate considerable hypothalamic, endocrine and metabolic alterations in HD. However, a comprehensive overview of these findings is lacking and their precise clinical significance is far from clear. Therefore, in this review we attempt to put these recent developments in the field into perspective by integrating them with previous findings in a comprehensible manner, and by discussing their clinical relevance, with a special focus on body weight, sleep and autonomic functions in HD, which will also allow for the identification of future lines of research in this area.
Similar articles
-
[The hypothalamus in Huntington's disease].Rev Neurol. 2017 Nov 1;65(9):415-422. Rev Neurol. 2017. PMID: 29071701 Review. Spanish.
-
Huntington's disease - new perspectives based on neuroendocrine changes in rodent models.Neurodegener Dis. 2009;6(4):154-64. doi: 10.1159/000225377. Epub 2009 Jun 12. Neurodegener Dis. 2009. PMID: 19521064 Review.
-
Hypothalamic and neuroendocrine changes in Huntington's disease.Curr Drug Targets. 2010 Oct;11(10):1237-49. doi: 10.2174/1389450111007011237. Curr Drug Targets. 2010. PMID: 20594177 Review.
-
Impaired hypothalamic endocrine function in neuroacanthocytosis.J Clin Neurosci. 2003 Nov;10(6):701-3. doi: 10.1016/s0967-5868(03)00166-8. J Clin Neurosci. 2003. PMID: 14592625
-
Hypothalamic alterations in Huntington's disease patients: comparison with genetic rodent models.J Neuroendocrinol. 2014 Nov;26(11):761-75. doi: 10.1111/jne.12190. J Neuroendocrinol. 2014. PMID: 25074766 Review.
Cited by
-
Is Dysregulation of the HPA-Axis a Core Pathophysiology Mediating Co-Morbid Depression in Neurodegenerative Diseases?Front Psychiatry. 2015 Mar 9;6:32. doi: 10.3389/fpsyt.2015.00032. eCollection 2015. Front Psychiatry. 2015. PMID: 25806005 Free PMC article. Review.
-
Microcirculation response to local cooling in patients with Huntington's disease.J Neurol. 2012 May;259(5):921-8. doi: 10.1007/s00415-011-6279-3. Epub 2011 Oct 20. J Neurol. 2012. PMID: 22012332
-
A 24-Hour Study of the Hypothalamo-Pituitary Axes in Huntington's Disease.PLoS One. 2015 Oct 2;10(10):e0138848. doi: 10.1371/journal.pone.0138848. eCollection 2015. PLoS One. 2015. PMID: 26431314 Free PMC article.
-
Epigenetic events influencing the biological clock: Panacea for neurodegeneration.Heliyon. 2024 Oct 2;10(19):e38836. doi: 10.1016/j.heliyon.2024.e38836. eCollection 2024 Oct 15. Heliyon. 2024. PMID: 39430507 Free PMC article. Review.
-
Non-motor symptoms in Huntington's disease: a comparative study with Parkinson's disease.J Neurol. 2019 Jun;266(6):1340-1350. doi: 10.1007/s00415-019-09263-7. Epub 2019 Mar 5. J Neurol. 2019. PMID: 30834978
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical